`
According to Fortune Business Insights, the global radiotherapy market size was valued at USD 6.05 billion in 2025 and is projected to grow from USD 6.39 billion in 2026 to USD 10.41 billion by 2034, exhibiting a CAGR of 6.3% during the forecast period. North America dominated the global radiotherapy market with a market share of 42.98% in 2025.
Radiotherapy is a cancer treatment method that uses high-energy radiation to destroy tumor cells and shrink tumors. Increasing prevalence of cancer types such as lung cancer, breast cancer, and prostate cancer, along with advancements in radiation therapy technologies, are driving demand for radiotherapy systems. The growing preference for non-invasive treatment approaches further supports market expansion.
MARKET DYNAMICS
Market Drivers
Increasing Prevalence of Cancer
Rising incidence of cancers, including lung and breast cancer, is increasing demand for radiotherapy procedures. Growing use of combination therapies and ongoing R&D efforts to develop advanced devices are supporting market growth.
Market Restraints
High Cost of Radiation Therapy Systems
High installation costs, infrastructure requirements, and maintenance expenses limit adoption of advanced radiotherapy systems. Establishing proton therapy facilities requires significant capital investment, restricting market penetration in developing regions.
Market Opportunities
Increasing Adoption of Proton Therapy
Proton therapy offers reduced toxicity and precise dose delivery. Growing installation of proton therapy units and favorable reimbursement policies are creating opportunities for market expansion.
Market Challenges
Limited Healthcare Expenditure in Developing Countries
Limited healthcare infrastructure, shortage of trained professionals, and inadequate reimbursement frameworks restrict adoption of advanced radiotherapy technologies.
Get Sample PDF Here: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/radiotherapy-market-114906
RADIOTHERAPY MARKET TRENDS
Technological Advancements in Radiotherapy Devices
Advances such as proton therapy, adaptive radiotherapy, magnetic resonance-guided therapy, and AI integration are improving treatment precision and workflow efficiency. These developments are increasing adoption of advanced radiotherapy systems.
SEGMENTATION ANALYSIS
By Product Type
The market is segmented into hardware and software. The hardware segment dominates due to rising demand for advanced radiation therapy devices such as linear accelerators and proton therapy systems.
By Type
Types include external beam radiotherapy, internal radiation therapy (brachytherapy), and systemic radiotherapy. External beam radiotherapy dominates due to widespread installation of linear accelerator systems.
By Application
Applications include breast cancer, prostate cancer, lung cancer, gynecological cancer, and others. Breast cancer dominates due to increasing prevalence globally.
By End-User
End-users include hospitals & clinics, radiotherapy centers, and others. Hospitals & clinics dominate due to availability of advanced infrastructure and increasing cancer treatment procedures.
REGIONAL ANALYSIS
North America
North America dominates the market due to advanced healthcare infrastructure, high cancer prevalence, and strong reimbursement policies.
Europe
Europe is witnessing growth due to adoption of advanced radiotherapy technologies and centralized cancer treatment centers.
Asia Pacific
Asia Pacific is expanding due to increasing cancer incidence, growing healthcare investments, and expanding radiotherapy infrastructure.
Latin America
Latin America is experiencing moderate growth due to improving healthcare access and increasing demand in urban areas.
Middle East & Africa
The Middle East & Africa region is witnessing gradual growth supported by expanding healthcare facilities.
Get Sample PDF Here: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/radiotherapy-market-114906
COMPETITIVE LANDSCAPE
Key companies operating in the radiotherapy market include:
- GE Healthcare
- Accuray Incorporated
- Elekta
- Hitachi High-Tech Corporation
- Koninklijke Philips N.V.
- Canon Medical Systems Corporation
- Brainlab SE
- Siemens Healthineers AG
- IBA Worldwide
- Novartis AG …and others.
KEY INDUSTRY DEVELOPMENTS
- May 2025: Standard Imaging introduced next-generation QA systems.
- June 2024: LEO Cancer Care collaborated with TibaRay for LINAC development.
- May 2024: GE Healthcare launched Revolution RT CT solution.
- February 2024: Siemens Healthineers received FDA approval for radiotherapy systems.
- June 2021: Accuray launched RayStation treatment planning support.
REPORT COVERAGE
The radiotherapy market report provides insights into market size, segmentation, regional outlook, and competitive landscape. It highlights technological advancements, increasing cancer prevalence, and growing demand for non-invasive treatments. These factors are expected to drive market growth during the forecast period.
`
Top comments (0)